Share
Market Research Report

GLOBAL CHOLERA VACCINES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Product TypeVaxchora · Dukoral · ShanChol · Euvichol-Plus/Euvichol · Others
  • By Vaccine TypeKilled Whole-cell and Recombinant Cholera Toxin B Vaccine · Killed Whole-cell Only Vaccines · Live Attenuated Oral Cholera · Vaccine
  • By Patient TypePediatric · Adults
  • By Distribution ChannelPublic · Private
  • By GeographyNorth America · Europe · Asia Pacific · Latin America · Middle East and Africa
  • Published In27 Mar 2026
  • Report CodeCMI6646
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033

Market Segmentation

  • By Product Type (Revenue, USD Mn, 2021 - 2033)

    • Vaxchora
    • Dukoral
    • ShanChol
    • Euvichol-Plus/Euvichol
    • Others (Late Phase Vaccines, etc.)
  • By Vaccine Type (Revenue, USD Mn, 2021 - 2033)

    • Killed Whole-cell and Recombinant Cholera Toxin B Vaccine
    • Killed Whole-cell Only Vaccines
    • Live Attenuated Oral Cholera Vaccine
  • By Patient Type (Revenue, USD Mn, 2021 - 2033)

    • Pediatric
    • Adults
  • By (Revenue, USD Mn, 2021 - 2033)

    Distribution Channel

    • Public
    • Private
  • By Region (Revenue, USD Mn, 2021 - 2033)

    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC Countries
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • North Africa
      • Central Africa